- Home
- XBIT
XBIT
XBiotech Inc.
as 11-15-2024 4:00pm EST
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
Upcoming Earnings Alert:
Get ready for potential market movements as XBiotech Inc. XBIT prepares to release earnings report on 22 Nov 2024.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | AUSTIN |
| Market Cap: | 217.5M | IPO Year: | 2015 |
| Target Price: | N/A | AVG Volume (30 days): | 54.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.51 - $9.96 | Next Earning Date: | 11-22-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest XBiotech Inc. News
XBIT Breaking Stock News: Dive into XBIT Ticker-Specific Updates for Smart Investing
Associated Press Finance
3 months ago
XBiotech: Q2 Earnings Snapshot
GlobeNewswire
5 months ago
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
Associated Press Finance
6 months ago
XBiotech: Q1 Earnings Snapshot
Simply Wall St.
9 months ago
XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 44% stake, while 44% is held by insiders
Zacks
10 months ago
Strength Seen in Silence Therapeutics PLC Sponsored ADR (SLN): Can Its 15.4% Jump Turn into More Strength?
GuruFocus.com
10 months ago
Chuck Royce Adjusts Position in Universal Stainless & Alloy Products Inc
GlobeNewswire
10 months ago
Evolution Petroleum Schedules Fiscal Second Quarter 2024 Earnings Release and Conference Call
Zacks
10 months ago
Evolution Petroleum (EPM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Compare XBIT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XBIT XBiotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.